ArticlePharmaceuticals (Basel, Switzerland)2022

Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer.

Truc T Huynh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.